IL17A and Alzheimer disease: RT‒qPCR analysis revealed significantly decreased Il4 and Il17a expression in the SSKO skin lesions following γδTCR antibody treatment (Fig. 6J), suggesting that dermal γδT cells contribute to the potentiation of type 2 (Th2) immune responses in AD-like SSKO skin.